Cargando…

Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe

Borrelia miyamotoi disease is a hard tick–borne relapsing fever illness that occurs across the temperate climate zone. Human B. miyamotoi disease in immunocompetent patients has been described in Russia, North America, and Japan. We describe a case of B. miyamotoi disease in an immunocompetent patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoornstra, Dieuwertje, Koetsveld, Joris, Sprong, Hein, Platonov, Alexander E., Hovius, Joppe W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106421/
https://www.ncbi.nlm.nih.gov/pubmed/30124426
http://dx.doi.org/10.3201/eid2409.180806
_version_ 1783349775587868672
author Hoornstra, Dieuwertje
Koetsveld, Joris
Sprong, Hein
Platonov, Alexander E.
Hovius, Joppe W.
author_facet Hoornstra, Dieuwertje
Koetsveld, Joris
Sprong, Hein
Platonov, Alexander E.
Hovius, Joppe W.
author_sort Hoornstra, Dieuwertje
collection PubMed
description Borrelia miyamotoi disease is a hard tick–borne relapsing fever illness that occurs across the temperate climate zone. Human B. miyamotoi disease in immunocompetent patients has been described in Russia, North America, and Japan. We describe a case of B. miyamotoi disease in an immunocompetent patient in western Europe.
format Online
Article
Text
id pubmed-6106421
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-61064212018-09-01 Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe Hoornstra, Dieuwertje Koetsveld, Joris Sprong, Hein Platonov, Alexander E. Hovius, Joppe W. Emerg Infect Dis Research Letter Borrelia miyamotoi disease is a hard tick–borne relapsing fever illness that occurs across the temperate climate zone. Human B. miyamotoi disease in immunocompetent patients has been described in Russia, North America, and Japan. We describe a case of B. miyamotoi disease in an immunocompetent patient in western Europe. Centers for Disease Control and Prevention 2018-09 /pmc/articles/PMC6106421/ /pubmed/30124426 http://dx.doi.org/10.3201/eid2409.180806 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Hoornstra, Dieuwertje
Koetsveld, Joris
Sprong, Hein
Platonov, Alexander E.
Hovius, Joppe W.
Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe
title Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe
title_full Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe
title_fullStr Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe
title_full_unstemmed Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe
title_short Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe
title_sort borrelia miyamotoi disease in an immunocompetent patient, western europe
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106421/
https://www.ncbi.nlm.nih.gov/pubmed/30124426
http://dx.doi.org/10.3201/eid2409.180806
work_keys_str_mv AT hoornstradieuwertje borreliamiyamotoidiseaseinanimmunocompetentpatientwesterneurope
AT koetsveldjoris borreliamiyamotoidiseaseinanimmunocompetentpatientwesterneurope
AT spronghein borreliamiyamotoidiseaseinanimmunocompetentpatientwesterneurope
AT platonovalexandere borreliamiyamotoidiseaseinanimmunocompetentpatientwesterneurope
AT hoviusjoppew borreliamiyamotoidiseaseinanimmunocompetentpatientwesterneurope